CSRxP advocates for bipartisan solutions that hold pharmaceutical companies accountable for egregious pricing and anti-competitive practices that are the root cause of out-of-control drug prices in America.
We believe in market-based reforms to lower drug prices for patients through increased transparency, competition and value.
Big Pharma’s business-as-usual playbook relies on egregious pricing practices and rhetoric designed to set and keep drug prices high.
Drug prices in the United States are out of control as a direct result of the egregious pricing and anti-competitive practices of brand name pharmaceutical companies. Rising prescription drug prices threaten the affordability of our health care system, the long-term health of our nation and the vitality of our entire economy. Public opinion research finds as many as one-in-three Americans experience financial difficulty, either as a patient themselves or through a family member, affording prescription drugs. CSRxP has developed market-based solutions to restore a functioning market and lower prices for patients by increasing list price transparency, promoting competition and actual innovation and focusing on better value for patients, not better value for pharmaceutical companies.
U.S. House Judiciary Subcommittee Hearing Builds Bipartisan Momentum for ETHIC Act and…
Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. Ruling Will Help Protect…
Lawmakers Should Advance the ETHIC Act and Skinny Labels, Big Savings Act to Address Big…
Health Care Leaders and Policy Experts Agree Bipartisan, Market-Based Solutions Would…
Two bipartisan solutions — the ETHIC Act and Skinny Labels… Read More
For far too long, Big Pharma has used the false excuse that research and… Read More
Committee Chairman Guthrie, Committee Ranking Member Pallone, Subcommittee… Read More
Big Pharma’s egregious pricing and anti-competitive practices are… Read More
Watch and learn about Big Pharma’s price-gouging techniques that are the cause of out-of-control drug prices.
Get the facts on Big Pharma’s anti-competitive tactics, like price-gouging and patent abuse that keeps drug prices high.
Learn about how Big Pharma is driving the Rx drug pricing crisis with our infographics.
See recent surveys on American voters’ opinions on Big Pharma’s blame game and out-of-control drug pricing.
Join us in telling lawmakers: It’s time to hold Big Pharma accountable and lower Rx drug prices.
